Why should Onivyde pegylated liposomal be avoided during pregnancy unless clearly necessary?

Onivyde pegylated liposomal should be avoided during pregnancy unless clearly necessary because adequate human pregnancy data are lacking and irinotecan's mechanism of action and embryotoxicity and teratogenicity in animals indicate potential harm to the foetus.